International launch of Cingal, the first HA-based viscosupplement plus steroid combination product for the treatment of osteoarthritis pain.
510(k) clearance received for the GFS Ultimate adjustable suture loop, further expanding the portfolio of graft fixation system (GFS) products2.
First surgery performed using the company’s first tissue-based product, the Glenojet® Allograft System for shoulder glenoid reconstruction1.
CE Mark approval received for Orthovisc®-T, a treatment designed to relieve pain and restore function for patients with chronic tennis elbow.